US6901451079 - Common Stock
/PRNewswire/ -- Rollins, Inc. (NYSE:ROL) ("Rollins" or the "Company"), a premier global consumer and commercial services company, today announced that Dale...
Outset Medical (OM) stock fell after RBC Capital Markets downgraded the company, citing a challenging outlook in 2024 amid a pause in TabloCart sales. Read more here.
Medical technology company Outset Medical expects revenue to grow by 12%-18% in 2024.
These stocks have been crushed by the market, but could be diamonds in the rough for patient investors.
Not all cheap stocks are good buys, but these two might be.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset" or the "Company") (NASDAQ: OM). Such investors...